Epigenetics in hepatocellular carcinoma

GP Nagaraju, B Dariya, P Kasa, S Peela… - Seminars in cancer …, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and
has a high fatality rate. Genetic and epigenetic aberrations are commonly observed in HCC …

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

M Chen, CM Wong - Molecular cancer, 2020 - Springer
Liver cancer is a common cancer worldwide. Although the etiological factors of liver
carcinogenesis are well defined, the underlying molecular mechanisms remain largely …

RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2

M Chen, L Wei, CT Law, FHC Tsang, J Shen… - Hepatology, 2018 - journals.lww.com
Epigenetic alterations have contributed greatly to human carcinogenesis. Conventional
epigenetic studies have predominantly focused on DNA methylation, histone modifications …

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets

R Liu, J Wu, H Guo, W Yao, S Li, Y Lu, Y Jia… - MedComm, 2023 - Wiley Online Library
Histones are DNA‐binding basic proteins found in chromosomes. After the histone
translation, its amino tail undergoes various modifications, such as methylation, acetylation …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Novel insights on m6A RNA methylation in tumorigenesis: a double-edged sword

S Wang, P Chai, R Jia, R Jia - Molecular cancer, 2018 - Springer
Abstract N6-methyladenosine (m 6 A), the most prevalent modification of mammalian RNA,
has received increasing attention. Although m 6 A has been shown to be associated with …

The role of histone methylation in the development of digestive cancers: a potential direction for cancer management

Y Chen, B Ren, J Yang, H Wang, G Yang… - Signal transduction and …, 2020 - nature.com
Digestive cancers are the leading cause of cancer-related death worldwide and have high
risks of morbidity and mortality. Histone methylation, which is mediated mainly by lysine …

Advanced nanotheranostics of CRISPR/Cas for viral hepatitis and hepatocellular carcinoma

H Kong, E Ju, K Yi, W Xu, YH Lao, D Cheng… - Advanced …, 2021 - Wiley Online Library
Liver disease, particularly viral hepatitis and hepatocellular carcinoma (HCC), is a global
healthcare burden and leads to more than 2 million deaths per year worldwide. Despite …

[HTML][HTML] Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg

MG Fernández-Barrena, M Arechederra, L Colyn… - Jhep Reports, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is a deadly tumour whose causative agents are generally
well known, but whose pathogenesis remains poorly understood. Nevertheless, key genetic …

EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms

A Nachiyappan, N Gupta, R Taneja - The FEBS Journal, 2022 - Wiley Online Library
Metastasis, therapy failure and tumour recurrence are major clinical challenges in cancer.
The interplay between tumour‐initiating cells (TICs) and epithelial–mesenchymal transition …